Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Université de Montréal
$105,000.00
Characterizing regulatory mechanisms of ARF1 activation in invasive breast cancer cells.
EF 2011-12
Résumé
Breast cancer is the most common form of cancer in North American women, with 1 in 9 women being diagnosed with
invasive breast cancer some time during her lifetime. The epidermal growth factor receptor (EGFR) has been shown to play
an important role in the initiation and progression of breast cancer. While current therapies targeting the EGFR are
successfully being used in the treatment of breast cancer, many patients are resistant to its actions. Therefore, it is essential
to develop other means of targeting the EGFR. We propose that the protein ARF1 may represent a novel target to diminish
the activities of EGFR. We have shown that ARF1 plays an important role in the growth of cancer cells and in metastasis
and that these actions are dependent on the EGFR. The current work will focus on further characterizing the role of ARF1 in
breast cancer and lead to the discovery of novel diagnostic and therapeutic tools that may be used in the treatment of breast
cancer.
Programme
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
257446
Name
Haines Eric
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Characterizing regulatory mechanisms of ARF1 activation in invasive breast cancer cells.
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Adaptor Proteins; Adp-Ribosylation Factor 1; Epidermal Growth Factor Receptor; Growth Receptor Binding Protein 2; Invasive Breast Cancer; Ras Activation; Receptor Signalling Cascades; Small Gtpases; Src Homology 2 Domain-Containing Protein; Src Kinase
Abstract
Breast cancer is the most common form of cancer in North American women, with 1 in 9 women being diagnosed with
invasive breast cancer some time during her lifetime. The epidermal growth factor receptor (EGFR) has been shown to play
an important role in the initiation and progression of breast cancer. While current therapies targeting the EGFR are
successfully being used in the treatment of breast cancer, many patients are resistant to its actions. Therefore, it is essential
to develop other means of targeting the EGFR. We propose that the protein ARF1 may represent a novel target to diminish
the activities of EGFR. We have shown that ARF1 plays an important role in the growth of cancer cells and in metastasis
and that these actions are dependent on the EGFR. The current work will focus on further characterizing the role of ARF1 in
breast cancer and lead to the discovery of novel diagnostic and therapeutic tools that may be used in the treatment of breast
cancer.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Haines, Eric
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~